发明名称 |
VERFAHREN ZUR DIAGNOSE ODER ZUR PROGNOSE VON ALZHEIMER KRANKHEIT: THERAPEUTISCHE ZUSAMMENSETZUNG ZUR VERHINDERUNG ODER ZUR BEHANDLUNG VON ALZHEIMER KRANKHEIT |
摘要 |
The invention relates to a method of predicting an increased risk of a patient having Alzheimer's disease (AD) or for a subject of developing AD comprising : a) assaying a DNA-containing biological sample for the allele of the APOE gene ; b) assaying the plasmatic level of protein Lp(a) or glycoprotein Apo(a), wherein the presence of an epsilon 4 allele of the APOE gene and an increased plasmatic level of Lp(a)/Apo(a) indicates an increased risk for the patient having Alzheimer's disease or developing AD. The invention further provides a therapy for preventing or treating AD consisting of decreasing the plasmatic level of Lp(a) or the interaction of Lp(a) with its receptor in a patient bearing at least one APOE epsilon 4 allele. |
申请公布号 |
AT225405(T) |
申请公布日期 |
2002.10.15 |
申请号 |
AT19990401742T |
申请日期 |
1999.07.09 |
申请人 |
INSTITUT PASTEUR DE LILLE;CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS DE LAUSANNE;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) |
发明人 |
MOOSER, VINCENT;HELBECQUE, NICOLE;AMOUYEL, PHILIPPE |
分类号 |
G01N33/53;A61K31/132;A61K31/198;A61K31/20;A61K31/203;A61K31/58;A61K31/7088;A61K38/00;A61K38/16;A61K38/17;A61K38/55;A61K39/395;A61K45/00;A61P25/28;C12Q1/02;C12Q1/68;G01N33/92;(IPC1-7):C12Q1/68;G01N33/68;A61K38/46 |
主分类号 |
G01N33/53 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|